Megestrol Acetate for Fatigue Management in T-DXd Treated Breast Cancer

NCT07543536 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Advanced/Metastatic Breast Cancer
HER2+, Low, or Ultralow Advanced/Metastatic Breast Cancer

Interventions

DRUG: Megestrol Acetate + Trastuzumab Deruxtecan
DRUG: Placebo + Trastuzumab Deruxtecan

Sponsor

Sun Yat-sen University